PATHOSEQ BIO, LLC

PATHOSEQ BIO, LLC specializes in advanced genomic analysis and sequence-based detection of biological threats, delivering high-complexity research and laboratory services to defense and public health stakeholders. The company’s core expertise lies in next-generation sequencing platforms, bioinformatics pipeline development, and real-time pathogen identification from complex clinical and environmental samples. Their work focuses on enabling rapid detection of biothreat agents through molecular diagnostics, with a strong emphasis on data-driven genomic characterization for defense and medical research applications. Key differentiators include deep proficiency in metagenomic analysis, reference genome alignment, and automated annotation of unknown microbial signatures, positioning them as a technical specialist in high-throughput, mission-critical biosecurity analytics. The contractor maintains a consistent and focused relationship with the Department of Defense, delivering end-to-end research and laboratory services that support biological defense initiatives. Their engagements involve genomic surveillance, pathogen discovery, and medical R&D aimed at enhancing situational awareness of emerging infectious threats. This sustained partnership reflects a trusted role in supporting DoD’s biodefense and force health protection missions through scientifically rigorous, laboratory-validated methodologies. PATHOSEQ BIO, LLC operates primarily under NAICS 541715 for research and development in life sciences and NAICS 621511 for medical laboratory services. These codes reflect their dual role as both a research innovator and a certified diagnostic provider, specializing in the intersection of genomics and defense medicine. Their market positioning is that of a niche technical provider serving high-stakes government biosecurity needs, distinct from broad clinical lab operators. As a small business structured as 2J, PATHOSEQ BIO, LLC is headquartered in Omaha, Nebraska, with no federal certifications listed. Their geographic presence is centralized, but their technical capabilities support national defense and public health missions through remote data analysis and laboratory collaboration. The company is positioned as a specialized, agile provider in the government’s evolving biodefense ecosystem.